Low Dose Allergy Immunotherapy (LDI)

LDI for Lyme disease

Low Dose Allergy Immunotherapy (LDI) for Lyme Disease

LDI is an extremely low dose immunotherapy that uses broad-based mixtures of allergens (antigens) made immunologically active by the enzyme glucuronidase. Allergy occurs when the immune system no longer tolerates the external environment. Auto Immune Disease  Autoimmune disease occurs when the immune system no longer tolerates the internal environment of the body. LDI helps restore immune tolerance to the environment outside and inside the body.

More about LDI Treatment:

Patient Experience

Click “View Results” at the bottom of Poll

The Low Dose Immunotherapy Handbook: Recipes and Lifestlye Advice for Patients on LDA and EPD Treatment

Back To:

Lyme Disease Protocols, and Healing Aids





Share This
Pin on PinterestShare on FacebookTweet about this on TwitterShare on StumbleUponShare on Google+

Leave a Reply

Your email address will not be published.